BX, the ticker for Blackstone Inc., represents the common stock of the world's largest alternative asset manager. The $140 central target reflects a review of roughly two dozen individual, current analyst price targets rather than any single firm's view. The arithmetic mean of the verified targets came to approximately $138, which rounds to $140 for a reader-friendly figure. Targets ranged from $118 (UBS) to $169 (RBC Capital).
The spread is unusually wide and tells a clear story. More cautious names sit near the current price: UBS at $118, Keefe, Bruyette & Woods at $119, Wells Fargo at $122, Barclays at $124, and Goldman Sachs at $125. More constructive firms cluster higher: Bank of America at $134, J.P. Morgan at $135, Deutsche Bank at $138, Morgan Stanley at $165, Oppenheimer at $168, and RBC Capital at $169. Recent action has been two-way — Deutsche Bank cut its target to $138 from $149 while keeping a Buy, Morgan Stanley trimmed to $165 from $184 on an Overweight rating, while BofA raised to $134 from $122. The overall posture remains a consensus "Buy" or "Moderate Buy," with no Sell ratings among current coverage. I also checked this using Tickeron’s AI Screener to see how BX compares to others in the industry.
Blackstone shares traded around $118 in late October 2026, well below their 52-week high near $190 but above the 52-week low near $102. Reaching the $140 average target would require a move of about 19%, a substantial repricing that would still leave the stock far beneath its prior peak.
The path likely hinges less on headline growth than on the composition of earnings. Analysts broadly expect management-fee growth to remain solid but slower in 2026, with a more meaningful step-up in performance-related revenue anticipated in 2027. Because the firm's fee-related earnings are increasingly anchored by long-dated assets in credit, infrastructure, and insurance, the stock's valuation depends heavily on how confidently the market prices that durability.
Technically, the stock has been consolidating near the bottom of a wide range. The 52-week range runs from roughly $102 to $190, with a recent low near $116 acting as initial support level. Below that, the $102 area marks the next meaningful floor. On the upside, resistance is likely to build first around $125–$130, where several analyst targets and prior trading cluster, before the $140 target zone and then the $150 area. The $120 and $130 levels are natural psychological markers investors watch closely.
Analyst price targets generally reflect a roughly 12-month research horizon, though firms set their own timeframes, and this should be treated as directional rather than precise. Investors should monitor quarterly earnings and guidance for signs of management-fee momentum and realization activity, analyst target revisions, capital deployment announcements in AI and infrastructure, insurance and private-credit fund flows, and the interest-rate backdrop. Distribution growth and changes in AUM are also leading indicators of fee durability. No single item will determine whether the $140 level is reached; the interaction of these factors will.
In my own work, I have found Tickeron’s AI Daily Buy/Sell Signals helpful for tracking shifts in BX and similar names. These signals apply artificial intelligence to monitor thousands of stocks and ETFs, producing Buy, Sell, or Hold recommendations based on technical behavior and market conditions. Pairing them with the analyst framework outlined above adds a timely, data-driven perspective without replacing fundamental review.
The question of whether BX can reach $140 ultimately rests on execution, not aspiration. The $140 figure is a mathematical average of analyst views spanning $118 to $169, and it sits roughly 19% above the current price. The bullish case is grounded in Blackstone's unmatched scale, its exposure to AI-related infrastructure and private credit, and improving fee-quality from insurance. The bearish case centers on muted realizations, decelerating near-term fee growth, and a premium valuation. With consensus still tilted "Buy" but individual targets spread widely, investors should watch earnings quality, realization trends, and rate developments rather than treat the $140 average as a guarantee.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Moving Average Convergence Divergence (MACD) for BX turned positive on October 19, 2026. Looking at past instances where BX's MACD turned positive, the stock continued to rise in 30 of 37 cases over the following month. The odds of a continued upward trend are 81%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BX's RSI Oscillator exited the oversold zone, 23 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on BX as a result. In 55 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
Following a +3.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where BX advanced for three days, in 203 of 297 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.
BX broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BX entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 32 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. BX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 88 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BX's P/B Ratio (9.823) is slightly higher than the industry average of (2.393). P/E Ratio (26.391) is within average values for comparable stocks, (-3.286). Projected Growth (PEG Ratio) (1.048) is also within normal values, averaging (1.319). Dividend Yield (0.044) settles around the average of (0.272) among similar stocks. P/S Ratio (7.148) is also within normal values, averaging (15.798).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of investment and fund management services
Industry InvestmentManagers